Cargando…
Current Controversies in Radiofrequency Ablation Therapy for Barrett’s Esophagus
Barrett’s esophagus (BE) is the most important risk factor for esophageal adenocarcinoma. Through the sequence of no dysplasia to low-grade dysplasia (LGD) and high-grade dysplasia (HGD), eventually early cancer (EC) may develop. The risk of neoplastic progression is relatively low, 0.5–0.9 % per pa...
Autores principales: | Belghazi, Kamar, Cipollone, Ilaria, Bergman, Jacques J. G. H. M., Pouw, Roos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783441/ https://www.ncbi.nlm.nih.gov/pubmed/26891725 http://dx.doi.org/10.1007/s11938-016-0080-4 |
Ejemplares similares
-
The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus
por: Eluri, Swathi, et al.
Publicado: (2015) -
Refractory Esophageal Strictures: What To Do When Dilation Fails
por: van Boeckel, Petra G. A., et al.
Publicado: (2015) -
Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis
por: Greer, K B, et al.
Publicado: (2013) -
A single-step sizing and radiofrequency ablation catheter for circumferential ablation of Barrett's esophagus: Results of a pilot study
por: Belghazi, K, et al.
Publicado: (2018) -
Managing Barrett’s esophagus with radiofrequency ablation
por: Akiyama, Junichi, et al.
Publicado: (2013)